UBS Group’s Clover Leaf Capital Corp. Class A Common Stock CLOE Stock Holding History

UBS Group’s Portfolio CLOE Stock Details CLOE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-350	Closed	-$4.27K	–	10381
2024 Q2	$4.27K	Buy	+350	New	+$4.27K	﹤0.01%	8114
2023 Q1	–	Sell	-2,452	Closed	-$26.5K	–	10722
2022 Q4	$26.5K	Sell	2,452 -205	-8%	-$2.17K	﹤0.01%	7369
2022 Q3	$27K	Buy	2,657 +1,999	+304%	+$20.4K	﹤0.01%	7019
2022 Q2	$7K	Sell	658 -500	-43%	-$5.05K	﹤0.01%	8564
2022 Q1	$12K	Buy	1,158 +208	+22%	+$2.08K	﹤0.01%	8215
2021 Q4	$9K	Buy	950 +500	+111%	+$4.99K	﹤0.01%	8946
2021 Q3	$4K	Buy	+450	New	+$4.47K	﹤0.01%	8706

Other funds holding CLOE

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

UBS Group's CLOE Position: Q3 2024 in Review

UBS Group sold out of Clover Leaf Capital Corp. Class A Common Stock (CLOE) in Q3 2024, closing a stake of 350 shares — an estimated $4.27K sold.

UBS Group first reported a position in CLOE in Q3 2021 and held it in 7 quarters. The position peaked at $27K in Q3 2022. 2 funds tracked by Wall St. Rank hold CLOE as of Q3 2024.

UBS Group reported no remaining Clover Leaf Capital Corp. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
UBS Group sold 350 Clover Leaf Capital Corp. Class A Common Stock shares in Q3 2024, an estimated $4.27K.
UBS Group first reported a position in Clover Leaf Capital Corp. Class A Common Stock in Q3 2021 and held it in 7 quarters.
UBS Group's Clover Leaf Capital Corp. Class A Common Stock position peaked at $27K in Q3 2022.
2 funds tracked by Wall St. Rank held Clover Leaf Capital Corp. Class A Common Stock as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.